Subcutaneous Lecanemab for Early Alzheimer Disease: Evidence, Safety, and Patient Selection
Aug 20, 2026 - 00:11:37
Radio and PodcastLive Radio & PodcastsHealth
Next-Generation CNS Drug Delivery: Brainshuttle Technology and Clinical Implications in Alzheimer Disease
No Label: Luka Kulic, MD In this episode, Luka Kulic, MD, Vice President and Global Head of Early Clinical Development in Neuroscience and Rare Diseases at Roche, Basel, Switzerland, discusses the investigational Brainsh...
About This Episode
Next-Generation CNS Drug Delivery: Brainshuttle Technology and Clinical Implications in Alzheimer Disease is an episode from NeuroFrontiers by ReachMD. No Label: Luka Kulic, MD In this episode, Luka Kulic, MD, Vice President and Global Head...
Podcast
This episode belongs to NeuroFrontiers.
Listen Online
Use the player on this page to stream the episode online.
Episode Details
Published Jul 17, 2026, 00:15:25 long, audio available.
Related Episodes
Continue listening to more episodes from NeuroFrontiers.
Advancing MOGAD Care
Jun 24, 2026 - 00:10:04
Multidisciplinary Coordination in TK2d Diagnosis and Management
Jun 24, 2026 - 00:11:15
Navigating Stem Cell Therapy Conversations in MS
Jun 8, 2026 - 00:04:45
Cognitive Screening in MS: Practical Strategies and Modern Approaches
May 28, 2026 - 00:03:30
Identifying the Respiratory Manifestations of TK2d: The Pulmonologist’s Role
May 14, 2026 - 00:14:45
Recognizing TK2d: Key Clinical Signs and Diagnostic Protocols
May 14, 2026 - 00:13:30
Understanding Variability in Myasthenia Gravis
May 1, 2026 - 00:03:45